Cytosponge - a ‘sponge on a string’

A Cytosponge is a simple device comprising a capsule attached to a string. After being swallowed the capsule dissolves inside the stomach, the sponge within it inflates, and the device is pulled back up the oesophagus, collecting cells along the way. 

The sponge and cells collected are sent for analysis to detect whether an individual has Barrett’s oesophagus, a condition that sometimes develops prior to oesophageal cancer.


Cytosponge technology enables any possible cancers to be detected at an earlier stage than usual. As people often don’t realise they have oesophageal cancer until later when symptoms are more noticeable. The alternative to using Cytosponge would be to have an endoscopy test.

In the East of England, Cytosponge tests are being piloted in some hospital trusts across the region as part of Project Delta, which aims to improve diagnosis of oesophageal cancer, using algorithms to identify individuals at most risk and offering them Cystosponge tests.

The East of England Cancer Alliances are also supporting four trusts in the East of England (two in the North and two in the South), to undertake an additional pilot during 2021, for patients with reflux referred into hospital by their GP.

Further information on Cytosponge can be found in a BBC News Report that can be viewed here, and on the CRUK Cambridge Centre website.

Dr Oliver Stovin, NHS Cambridgeshire and Peterborough CCG, discusses the use of Cytosponge technology. 

Watch Oliver's short introductory video (see right):

(This is an introduction to the BBC interview by Professor Rebecca Fitzgerald)